Search

everythinglearnresearchcommunity

for

Search:↓

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

Chemotherapy for prostate, bladder, and testicular cancer patients commonly causes hair loss, fatigue, and decreased appetite.

Research on non-muscle invasive bladder cancer has increased, with the U.S. leading, and highlights effective treatments like BCG despite some side effects.

Permanent hair dye use may increase bladder cancer risk, especially in female smokers with certain genetic traits.

Finasteride does not prevent bladder cancer.

Lower levels of MYLK and CALD1 in bladder cancer and osteosarcoma are linked to worse survival rates.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Six key genes can predict bladder cancer outcomes and may serve as prognostic biomarkers.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

Taking 5-Alpha Reductase Inhibitors before bladder removal surgery might make high-grade bladder tumors less aggressive.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

Pumpkin seeds may improve health due to their rich nutrients and potential to treat various conditions.

Herbal hair dyes are safer and eco-friendly compared to synthetic dyes.

Androgens may influence bladder cancer progression by affecting cellular behavior.

Polypoid cystitis can mimic bladder cancer but can be effectively treated with surgery, stents, and medication.

A woman developed severe bladder inflammation after cancer treatment with Cytoxan.

Cyclophosphamide can cause serious short-term and long-term side effects, including increased cancer risk and infertility.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

Targeting Keratin 17 may help overcome cancer therapy resistance.

Pumpkin roots contain compounds like Alpha-spinasterol, squalene, and palmitic acid, which may have health benefits like reducing depression, treating certain cancers, and having antibacterial properties.

Selenium supplements do not prevent cancer and may have harmful effects.

5α-reductase inhibitors may lower the risk of death from bladder cancer.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Finasteride use is linked to a lower risk of bladder cancer, especially in Caucasians and Hispanics.

Cancer prevention has advanced significantly, with some strategies proving successful.